---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-035767"
form_type: "8-K"
ticker: "HROW"
cik: "0001360214"
company_name: "HARROW, INC."
filed_at: "2022-12-16T23:59:59+00:00"
generated_at: "2026-06-21T03:12:34.037771+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Harrow Health secures $125M financing package (notes, equity, loan) to fund acquisition

## Summary
- Common stock offering: 2,376,426 shares at $10.52 for gross proceeds of $25M, closed Dec 16.
- Senior notes offering: $35M principal of 11.875% notes due 2027, priced Dec 16, closing expected Dec 20.
- B. Riley affiliate committed $65M secured loan at 10.875% fixed interest rate.
- Management and directors purchased $950,000 of the senior notes.
- Proceeds, along with sale of non-ophthalmology assets, to fund recently announced acquisition and general purposes.

## SEC filing metadata
- accession: 0001493152-22-035767
- form_type: 8-K
- ticker: HROW
- cik: 0001360214
- company_name: HARROW, INC.
- filed_at: 2022-12-16T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1360214/000149315222035767/0001493152-22-035767-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1360214/000149315222035767/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-035767
- JSON: https://secwatch.observer/filing/0001493152-22-035767.json
- Plain text: https://secwatch.observer/filing/0001493152-22-035767.txt

## Key facts
- Material Agreements
  HARROW, INC. entered into Common Stock Underwriting Agreement with B. Riley Securities, Inc. valued at gross proceeds of $25,000,002 (effective 2022-12-13).
  - Action: entry
  - Agreement: underwriting
  - Counterparty: B. Riley Securities, Inc.
  - Value: gross proceeds of $25,000,002
  - Effective: 2022-12-13
  source text: On December 13, 2022, Harrow Health, Inc. (the “Company”) entered into an underwriting agreement (the “ Common Stock Underwriting Agreement ”) with B. Riley Securities, Inc. (the “ Common Stock Underwriter ”) related to a registered direct offering of shares of the Company’s common stock
  evidence_url: https://www.sec.gov/Archives/edgar/data/1360214/000149315222035767/0001493152-22-035767-index.htm
- Material Agreements
  HARROW, INC. entered into Notes Underwriting Agreement with B. Riley Securities, Inc., as representative of the several underwriters named therein valued at $35,000,000 aggregate principal amount of 11.875% Senior Notes due 2027 (effective 2022-12-15).
  - Action: entry
  - Agreement: notes offering
  - Counterparty: B. Riley Securities, Inc., as representative of the several underwriters named therein
  - Value: $35,000,000 aggregate principal amount of 11.875% Senior Notes due 2027
  - Effective: 2022-12-15
  source text: On December 15, 2022, the Company entered into an underwriting agreement (the “ Notes Underwriting Agreement ”) with B. Riley Securities, Inc., as representative of the several underwriters named therein (the “ Notes Underwriters ”), pursuant to which the Company agreed to sell to the Notes Underwriters $35,000,000 aggregate principal amount of 11.875% Senior Notes due 2027
  evidence_url: https://www.sec.gov/Archives/edgar/data/1360214/000149315222035767/0001493152-22-035767-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.